The American healthcare system is currently navigating a pivotal shift in how medical necessity is determined, as the federal government introduces artificial intelligence into the contentious process of prior authorization. For decades, patients and physicians have viewed prior authorization—the requirement that providers obtain approval from an insurer before a specific procedure, test, or medication is covered—as a significant barrier to timely care. Now, the Trump administration has launched the Wasteful and Inappropriate Service Reduction (WISeR) model, a pilot program that employs AI to scrutinize claims in original Medicare. While proponents argue this technology will streamline administrative burdens and curb fraudulent spending, critics fear it is simply automating a system already plagued by systemic delays and wrongful denials.
The Anatomy of a Broken Process
Prior authorization was originally designed as a cost-containment tool, intended to ensure that healthcare resources were not squandered on unnecessary or experimental treatments. However, in practice, it has evolved into a frequent point of friction. According to the American Medical Association (AMA), a vast majority of physicians report that these requirements lead to significant delays in treatment, causing some patients to abandon their prescribed therapy entirely.
The process is notoriously cumbersome. A physician must submit documentation to an insurer’s review team, wait for a decision, and, if denied, navigate a complex and often opaque appeals process. Data from the Commonwealth Fund’s 2025 affordability survey highlights the human cost: roughly one in five working-age adults with private insurance reported that they or a family member were denied coverage for physician-recommended care. Of those who faced a denial, 41 percent reported that their care was delayed, and more than 25 percent indicated that their underlying health condition worsened as a direct result.
The Chronology of Regulatory Reform
The tension surrounding prior authorization has led to a series of federal interventions over the past several years. In 2024, the Biden administration finalized a rule designed to increase transparency and force health plans to adhere to stricter timelines. Under these regulations, insurers operating in the public sector were required to provide decisions on urgent requests within 72 hours and non-urgent requests within seven calendar days. These rules, which went into effect on January 1, 2025, were intended to bring much-needed predictability to a system that previously functioned without standardized response times.
Building on this, the current administration has sought to further refine the process. In addition to the implementation of the WISeR model, officials have pressured private insurers to standardize electronic health record (EHR) integration for prior authorization requests. Insurance industry leaders have pledged to standardize these electronic exchanges by 2027 and have committed to reducing the sheer volume of medical services that require prior authorization by 2026, specifically targeting low-risk procedures like cataract surgeries and routine colonoscopies.
The WISeR Model: AI as a New Gatekeeper
The WISeR model represents a departure from traditional human-led review in original Medicare. By leveraging machine learning, the program aims to identify patterns of overutilization and fraud across six states. The initiative specifically targets high-cost, high-frequency services, including electrical nerve stimulator implants, skin and tissue substitutes, and knee arthroscopy for osteoarthritis.
The mechanics of WISeR involve private vendors who are contracted to evaluate claims. These vendors are financially incentivized through a profit-sharing model tied to "averted expenditures." While CMS maintains that this will ensure only appropriate services are paid for, the model has faced immediate scrutiny. Health policy experts, including former insurance executives and researchers at the Center for Health & Democracy, have raised concerns that the incentive structure inherently encourages the denial of care. Investigations by news outlets have already indicated that, in the initial months of the pilot, the model has been associated with increased wait times and denials in the participating jurisdictions.
The "Arms Race" of Automation
A central critique of the integration of AI into this field is that it does not necessarily solve the problem of administrative waste; rather, it creates a digital "arms race." As insurers deploy increasingly sophisticated algorithms to issue denials, providers are forced to respond with equally automated systems to submit and appeal those denials.
Dr. Jared Dashevsky, a physician and founder of the healthcare platform Healthcare Huddle, has characterized this trend as the automation of a fundamentally flawed system. "AI could eliminate barriers and reduce administrative waste, giving us more time with patients," Dashevsky noted. "But that is not what is being built. Instead, there is an arms race to deny faster and appeal faster."
This sentiment is echoed by the AMA, which has repeatedly called for greater transparency in the algorithms used by insurers. Physicians are particularly concerned about the lack of clinical nuance in AI-driven decisions. In a 2025 survey, 61 percent of doctors expressed deep concern that AI would exacerbate the frequency of wrongful denials, as machines may struggle to account for the unique, complex clinical presentations of individual patients that do not fit into standardized, pre-programmed algorithms.
Official Responses and Future Implications
CMS Administrator Mehmet Oz has taken a firm stance with private insurers, warning that the federal government is prepared to impose strict regulations if the industry does not self-correct. "If you don’t do it yourselves, then we’re going to do it for you," Oz stated during a recent appearance on the National News Desk.
In response, the insurance industry has attempted to demonstrate progress. Recent data from industry groups suggest that, between June 2025 and April 2026, prior authorization requests declined by 11 percent. Furthermore, major health plans have publicly stated that they do not use AI or algorithms to issue "final" denials of medical necessity without human clinical review.
However, the efficacy of these pledges remains a subject of debate. While the promise of human oversight is intended to placate critics, it does little to address the underlying data-driven bias that may inform the AI’s initial recommendation to deny a claim. Moreover, the lack of transparency regarding how these algorithms are trained—and what specific criteria they prioritize—continues to be a major sticking point for patient advocacy groups.
A System at a Crossroads
The broader impact of this technological pivot is yet to be fully realized. If the WISeR model successfully identifies and eliminates genuine fraud, it could provide a roadmap for more efficient government spending. Conversely, if it results in the systematic denial of necessary care, it may trigger a significant legislative backlash. Several lawmakers have already introduced resolutions aimed at blocking funding for the WISeR model, citing concerns about patient access to care.
As the program continues through December 2031, its success or failure will likely hinge on the balance between automated efficiency and the preservation of clinical judgment. The current trajectory suggests that while the tools of the trade are becoming more sophisticated, the core conflict remains unchanged: the tension between the financial interests of those paying for care and the clinical needs of the patients receiving it. Whether AI ultimately acts as a bridge to a more efficient system or a wall that further separates patients from their treatment remains the defining question of this healthcare era. For now, the transition to AI-managed prior authorization is not merely a technical upgrade; it is a fundamental shift in the power dynamics of the American medical landscape.
